Somewhat Favorable News Coverage Extremely Likely to Affect Innospec (IOSP) Stock Price
Media coverage about Innospec (NASDAQ:IOSP) has trended somewhat positive this week, according to Accern Sentiment. Accern identifies positive and negative news coverage by monitoring more than 20 million blog and news sources. Accern ranks coverage of public companies on a scale of -1 to 1, with scores closest to one being the most favorable. Innospec earned a coverage optimism score of 0.13 on Accern’s scale. Accern also assigned media headlines about the specialty chemicals company an impact score of 97 out of 100, indicating that recent news coverage is extremely likely to have an effect on the company’s share price in the near future.
These are some of the news stories that may have effected Accern’s scoring:
- Kraton Corporation (KRA) versus Innospec (IOSP) Financial Contrast (americanbankingnews.com)
- Innospec Schedules Second Quarter 2017 Earnings Release and Conference Call (feeds.benzinga.com)
- Innospec, Inc. breached its 50 day moving average in a Bullish Manner : IOSP-US : July 13, 2017 (finance.yahoo.com)
- ETFs with exposure to Innospec, Inc. : July 13, 2017 (finance.yahoo.com)
- Zacks: Innospec Inc. (IOSP) Given $68.33 Consensus Target Price by Analysts (americanbankingnews.com)
Innospec (NASDAQ:IOSP) traded down 0.31% during trading on Monday, reaching $64.50. The company had a trading volume of 26,212 shares. Innospec has a 52-week low of $49.32 and a 52-week high of $74.75. The company has a market capitalization of $1.56 billion, a PE ratio of 19.79 and a beta of 1.17. The company has a 50 day moving average price of $64.75 and a 200 day moving average price of $66.08.
Innospec (NASDAQ:IOSP) last posted its quarterly earnings results on Tuesday, May 9th. The specialty chemicals company reported $1.00 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $0.86 by $0.14. The firm had revenue of $294.30 million for the quarter, compared to analyst estimates of $287 million. Innospec had a return on equity of 14.63% and a net margin of 8.24%. The business’s quarterly revenue was up 38.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.93 EPS. On average, equities analysts forecast that Innospec will post $4.10 EPS for the current fiscal year.
IOSP has been the topic of a number of research reports. BidaskClub downgraded Innospec from a “hold” rating to a “sell” rating in a report on Thursday, June 22nd. Zacks Investment Research downgraded Innospec from a “strong-buy” rating to a “hold” rating in a report on Wednesday, July 12th.
Innospec Company Profile
Innospec Inc is a specialty chemicals company engaged in developing, manufacturing, blending, marketing and supplying of specialty chemicals for use as fuel additives and ingredients for personal care, home care, agrochemical, mining and other applications and oilfield chemicals. The Company operates through four business segments: Fuel Specialties, Performance Chemicals, Oilfield Services and Octane Additives.
Receive News & Ratings for Innospec Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innospec Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.